Please assess the completion status of the following clinical trial:

Trial Title: Suppression of HIV 1 RNA in People Living With HIV

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* living with HIV~Exclusion Criteria:~* report current suicidal or homicidal ideation;~* have a severe psychiatric disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Incentive Group (Type: EXPERIMENTAL): Incentive group participants will receive the standard HIV medical care offered in their clinic. In addition, Incentive group participants will receive incentives for viral suppression. These incentives will be presented if the participants maintain suppressed and undetectable viral loads. The incentive program will employ high magnitude incentives, provide incentives for decreases in viral load early in treatment before a patient's viral load has reached undetectable levels, arrange frequent incentives early in treatment and reduce the frequency of incentives as participants achieve progressively longer periods of viral load suppression, arrange a schedule of escalating incentives for sustained suppression of viral load, and the intervention will be maintained for two years.
- Usual Care Group (Type: OTHER): Usual Care Control participants will receive the standard HIV medical care offered in their clinic.

Based on this trial design, predict the completion outcome and termination type (if applicable).